Suppr超能文献

糖尿病患者毛霉菌病的诱发因素:伊朗南部21年的经验

Predisposing Factors for Mucormycosis in Patients with Diabetes Mellitus; An Experience of 21 Years in Southern Iran.

作者信息

S Sarvestani Amene, Pishdad Gholamreza, Bolandparvaz Shahram

机构信息

Department of Surgery, Imam-Ali Hospital, Zahedan University of Medical Sciences, Zahedan, Iran.

Department of Internal Medicine, Endocrine and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

Bull Emerg Trauma. 2013 Oct;1(4):164-70.

Abstract

OBJECTIVES

To determine the prevalence and predisposing factors of mucormycosis in patients with diabetes mellitus (DM) in a Shiraz referral centers.

METHODS

This retrospective case control study, reviewed the medical records of 162 patients with pathologically confirmed diagnosis of mucormycosis hospitalized in two major Shiraz University hospitals during the last 21 years. For each diabetic patient, two patients with diabetic ketoacidosis (DKA) matched for age, sex and the date of admission was selected as control group. Age, type of diabetes mellitus (DM) and duration of involvement as well as paraclinical findings were compared between cases and controls.

RESULTS

There were 162 patients with murormycosis of which 30 (18.5%) had DM as predisposing factor. Diabetes was the second common predisposing disease next to leukemia. There were 19 (63.3%) women and 11 (36.7%) men among the patients. The overall mortality rate was 53.33% mortality rate. The mean age of the patients was 45.3 ± 17.6 years. The mean duration of diabetes in case and control groups were 5.75 ± 5.43 and 7.2 ± 7.85 years respectively, without any statistical significance between them (p=0.063). Blood sugar in patients was lower than control group (p=0.012). Serum bicarbonate level in case group was higher than in control group (p<0.001). Arterial pH in control group was more acidic than case group (p<0.001). Insulin dependent DM was significantly more prevalent in control group compared to case group (73.4% vs. 36.6%; p=0.002).

CONCLUSION

Our study showed that the number of hospitalized patients with mucormycosis over the last 7 years has been decreased which is due to better control of infection in diabetics. In addition to hyperglycemia and acidosis, several other unknown factors like immune defects may predispose diabetics to this fungal infection.

摘要

目的

确定设拉子转诊中心糖尿病患者毛霉菌病的患病率及易感因素。

方法

这项回顾性病例对照研究,回顾了过去21年在设拉子大学两所主要医院住院的162例经病理确诊为毛霉菌病患者的病历。对于每例糖尿病患者,选择两名年龄、性别和入院日期相匹配的糖尿病酮症酸中毒(DKA)患者作为对照组。比较病例组和对照组的年龄、糖尿病类型、受累时间以及辅助检查结果。

结果

162例毛霉菌病患者中,30例(18.5%)有糖尿病作为易感因素。糖尿病是仅次于白血病的第二常见易感疾病。患者中女性19例(63.3%),男性11例(36.7%)。总死亡率为53.33%。患者的平均年龄为45.3±17.6岁。病例组和对照组的糖尿病平均病程分别为5.75±5.43年和7.2±7.85年,两者之间无统计学意义(p=0.063)。患者的血糖低于对照组(p=0.012)。病例组血清碳酸氢盐水平高于对照组(p<0.001)。对照组动脉pH值比病例组更偏酸性(p<0.001)。与病例组相比,对照组胰岛素依赖型糖尿病的患病率显著更高(73.4%对36.6%;p=0.002)。

结论

我们的研究表明,过去7年住院毛霉菌病患者数量有所减少,这是由于糖尿病患者感染得到了更好的控制。除高血糖和酸中毒外,其他一些未知因素如免疫缺陷可能使糖尿病患者易患这种真菌感染。

相似文献

5
Hyperosmolarity and acidosis in diabetes mellitus: a three-year experience in Rhode Island.
J Gen Intern Med. 1991 Nov-Dec;6(6):495-502. doi: 10.1007/BF02598216.
6
Clinical predictors of mucormycosis in children with type 1 diabetes mellitus.
J Pediatr Endocrinol Metab. 2002 Jul-Aug;15(7):1001-4. doi: 10.1515/jpem.2002.15.7.1001.
10
Evaluation of 30 cases of mucormycosis at a university hospital in Iran.
Mycoses. 2017 Jul;60(7):426-432. doi: 10.1111/myc.12614. Epub 2017 Mar 20.

引用本文的文献

1
Miltefosine: A Repurposing Drug against Mucorales Pathogens.
J Fungi (Basel). 2023 Dec 4;9(12):1166. doi: 10.3390/jof9121166.
2
Histological Spectrum of Post Covid Debridement Tissues: Salient Histomorphological Features With Respect to Identification Fungal Elements.
Clin Pathol. 2022 Sep 30;15:2632010X221126987. doi: 10.1177/2632010X221126987. eCollection 2022 Jan-Dec.
3
Mucormycosis Amid COVID-19 Crisis: Pathogenesis, Diagnosis, and Novel Treatment Strategies to Combat the Spread.
Front Microbiol. 2022 Jan 4;12:794176. doi: 10.3389/fmicb.2021.794176. eCollection 2021.
4
Risk of Mucormycosis in Diabetes Mellitus: A Systematic Review.
Cureus. 2021 Oct 16;13(10):e18827. doi: 10.7759/cureus.18827. eCollection 2021 Oct.
5
Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World.
Mycopathologia. 2021 Dec;186(6):739-754. doi: 10.1007/s11046-021-00584-8. Epub 2021 Aug 19.
6
Mucormycosis: An opportunistic pathogen during COVID-19.
Environ Res. 2021 Oct;201:111643. doi: 10.1016/j.envres.2021.111643. Epub 2021 Jul 6.
7
Rhino-orbital Mucormycosis.
Bull Emerg Trauma. 2019 Jan;7(1):88-89. doi: 10.29252/beat-0701015.
8
Innate and Adaptive Immunity to Mucorales.
J Fungi (Basel). 2017 Sep 5;3(3):48. doi: 10.3390/jof3030048.

本文引用的文献

2
The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice.
J Clin Invest. 2010 Jun;120(6):1914-24. doi: 10.1172/JCI42164. Epub 2010 May 17.
3
Diabetic kidney disease: act now or pay later.
Saudi J Kidney Dis Transpl. 2010 Mar;21(2):217-21.
4
Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006.
Emerg Infect Dis. 2009 Sep;15(9):1395-401. doi: 10.3201/eid1509.090334.
5
The role of neutrophils in the development and outcome of zygomycosis in haematological patients.
Clin Microbiol Infect. 2009 Oct;15 Suppl 5:33-6. doi: 10.1111/j.1469-0691.2009.02977.x.
6
Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment.
Curr Opin Infect Dis. 2008 Dec;21(6):620-5. doi: 10.1097/QCO.0b013e3283165fd1.
7
Rhinocerebral Mucormycosis: consideration of prognostic factors and treatment modality.
Auris Nasus Larynx. 2009 Jun;36(3):274-9. doi: 10.1016/j.anl.2008.07.003. Epub 2008 Sep 10.
8
Malignant otitis externa.
Otolaryngol Clin North Am. 2008 Jun;41(3):537-49, viii-ix. doi: 10.1016/j.otc.2008.01.004.
10
Decrease in the number of reported cases of zygomycosis among patients with diabetes mellitus: a hypothesis.
Clin Infect Dis. 2007 Apr 15;44(8):1089-90. doi: 10.1086/512817. Epub 2007 Mar 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验